ELISA Development for the quantification of anti-drug IgG1 antibodies in animal sera
Description
Preclinical studies were performed for the development of a protein-based biopharmaceutical for the treatment of an auto-immune disease. The goal of the project is the development of an ELISA-based method for the detection and the quantification of potential anti-drug antibodies (ADA) in dog and rat sera.
Key Data
Projectlead
Project status
completed, 11/2019 - 12/2020
Institute/Centre
Institute of Chemistry and Biotechnology (ICBT)
Funding partner
Third party